Home
Decoding immunity
We are mapping the immune system at unprecedented scale & resolution to facilitate development of next-generation immune-related therapeutics.
Collaboration
Step inside our collaborations with AstraZeneca and Teva in drug discovery and development
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
Partnering with
Solutions
AMICA OS supports decision-making along the drug discovery & development journey to bring better therapies to patients.
Our platform helps pharma companies make smarter choices, reduce risks, and accelerate progress with three key solutions:
-
Target Discovery
Identify novel high impact targets linked to disease
-
Preclinical Evaluation
Prioritize the most promising drug candidates for development
-
Clinical Trial Optimization
Better understand drug mechanism of action, identify the right groups of patients and the best treatment strategies to maximize trial success
Drug development is a complex journey that requires critical decisions at every step.
Target Discovery
- Start
- Target Discovery
Preclinical Evaluation
- Lead Selection
Clinical Trial Optimization
- Dose Selection
- Drug MoA
- Patient Safety
- Patient Stratification
- Combination Prioritization
- FDA Approval
Platform
Integrated, end-to-end platform
Our integrated end-to-end platform components are designed to provide actionable clinical decision support, from therapeutic query to actionable recommendation.
-
AMICA-Lab
Single-cell profiling at the highest resolution
-
AMICA-DB
AMICA data foundation: the world’s largest harmonized immune cell atlas
-
AMICA-One
Immune foundation model trained on AMICA to predict drug response and resistance
-
AMICA-Reason
Agentic reasoning engine that turns model outputs into mechanistic, actionable narratives